RAFAEL HOLDINGS, INC. Cash Equivalents, at Carrying Value
RAFAEL HOLDINGS, INC. (RFL) had Cash Equivalents, at Carrying Value of $13.20 million as of 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2023-12-14
- 2023-10-31: Cash Equivalents, at Carrying Value $13.20M.
- 2023-01-31: Cash Equivalents, at Carrying Value $9.67M.
- 2022-10-31: Cash Equivalents, at Carrying Value $22.17M.
- 2022-07-31: Cash Equivalents, at Carrying Value $26.54M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2023-10-31 | $13.20M 10-Q · filed 2023-12-14 |
| 2023-01-31 | $9.67M 10-Q · filed 2023-03-14 |
| 2022-10-31 | $22.17M 10-Q · filed 2023-12-14 |
| 2022-07-31 | $26.54M 10-K · filed 2022-10-31 |
| 2022-04-30 | $28.96M 10-Q · filed 2022-06-14 |
| 2022-01-31 | $65.03M 10-Q · filed 2023-03-14 |
| 2021-10-31 | $72.39M 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $7.85M 10-K · filed 2022-10-31 |
| 2020-07-31 | $6.21M 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |